| Rusling Research Group

Our websites may use cookies to personalize and enhance your experience. By continuing without changing your cookie settings, you agree to this collection. For more information, please see our University Websites Privacy Notice.

Summary of Current Research

Patient biomarker levels for samples analyzed in the paper: Prostate Cancer Diagnosis in the Clinic with an 8-Protein Diagnostic Biomarker Panel, 2020

Abstracts from Recently Published Work

Chiral Biocatalytic Oxidations at 90 °C in Microemulsions Driven by Electrocatalytic Oxygen Reduction to Hydrogen Peroxide

Microfluidic device for multiplexed protein detection in serum

Microfluidic Immunoarray for Point-of-Care Detection of Cytokines in COVID-19 Patients

Design and Fabrication of a 3D-Printed Microfluidic Immunoarray for Ultrasensitive Multiplexed Protein Detection

COVID-19 Detection Using a 3D-Printed Micropipette Tip and a Smartphone

Proteins biomarkers captured from serum using magnetic beads with 400,000 HRP labels for ultrasensitive oral cancer detection

microfluidic device

oral cancer plots

ECL protein array with automated sample and reagent feed

Automated ECL light detection of 4 prostate cancer biomarker proteins in patient serum

ECL device

ECL results

High-throughput arrays and LC-MS approaches for genotoxicity screening

UPLC-MS/MS sequencing for metabolite-related gene damage of TP53, a tumor suppressor gene, and cancer prediction

3D printed biosensor arrays

SPR arrays for peanut allergy diagnostics

Peanut allergen antibody (IgE) detection in patient serum using SPRi